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Silicon nanoparticles are experimentally investigated as a potential hyperpolarized, targetable
MRI imaging agent. Nuclear T1 times at room temperature for a variety of Si nanoparticles are
found to be remarkably long (102 to 104 s)—roughly consistent with predictions of a core-shell
diffusion model—allowing them to be transported, administered and imaged on practical time scales
without significant loss of polarization. We also report surface functionalization of Si nanoparticles,
comparable to approaches used in other biologically targeted nanoparticle systems.
The use of nanoparticles for biomedical applications
has benefited from rapid progress in nanoscale synthesis
of materials with specific optical and magnetic proper-
ties, as well as biofunctionalization of surfaces, allow-
ing targeting1,2,3, in-vivo tracking3,4,5, and therapeutic
action6,7. For magnetic resonance imaging (MRI), super-
paramagnetic nanoparticles have extended susceptibility-
based contrast agents toward targeted imaging8, though
achieving high spatial resolution with high contrast re-
mains challenging. An alternative approach is direct
MRI of hyperpolarized materials with little or no back-
ground signal. Hyperpolarized noble gases9,10,11 and
13C-enhanced biomolecules12,13 have demonstrated im-
pressive image contrast, but are limited by short in-vivo
enhancement times (∼ 10 s for noble gases9, ∼ 30 s
for 13C biomolecules12,13). It is known that bulk sili-
con can exhibit multi-hour nuclear spin relaxation (T1)
times at room temperature14 and that silicon nanoparti-
cles can be hyperpolarized via dynamic nuclear polariza-
tion (DNP)15.
Nuclear magnetic resonance (NMR) in silicon has been
widely investigated for half a century14, and with re-
newed interest in the context of quantum computation16.
The low natural abundance of spin-1/2 29Si nuclei (4.7%)
embedded in a lattice of zero-spin 28Si nuclei isolates
the active nuclear spins from one another and from the
environment, leading to multi-hour spin relaxation (T1)
times, and decoherence (T2) times of tens of seconds16.
Moreover, the weak dipole-dipole coupling of the sparse
29Si atoms, together with the isotropic crystal structure
and the absence of nuclear electric quadrupole moment
conspire to keep any induced nuclear polarization aligned
with an external magnetic field, even as the nanoparticle
tumbles in space. This is critical for tracking hyperpo-
larized nanoparticles in a fluid suspension using MRI, as
the nuclear polarization direction can be fixed using a
small (mT-scale) applied field.
Particle size determines regimes of application to
biomedicine17 as well as predicted NMR properties15.
Here, we report NMR properties of Si particles span-
ning four orders of magnitude in mean diameter, from
∼40 nm nanoparticles to millimeter-scale granules. We
investigate particles made by ball milling high-resistivity
(30−100 kΩ-cm, residual p-type 〈111〉, Silicon Quest
International), and low-resisitivity (0.01 − 0.02 Ω-cm,
boron-doped (p-type), 〈100〉 oriented, Virginia Semicon-
ductor) commercial silicon wafers, followed by centrifu-
gal segregation by size18. We also investigate chem-
ically synthesized Si nanoparticles with mean diame-
ters 40 nm (Meliorum), 60 nm (Meliorum), 140 nm
(MTI) and 600 nm (NanoAmor), obtained commercially.
Figure 1 shows representative scanning electron micro-
scope (SEM) images of all measured particles, along with
volume-weighted size distributions obtained by SEM im-
age analysis. Dilute suspensions of silicon nanoparti-
cles in ethanol were sonicated for ten minutes before be-
ing pipetted onto a vitreous carbon planchett which was
mounted on a standard specimen holder with conducting
carbon tape. For each sample, > 1000 particles were an-
alyzed, sourced from ∼ 50 images, with particles in con-
tact excluded from the analysis. Particle agglomeration
seen in dry Meliorum and MTI samples has been reported
in similarly sized silica nanoparticles, but is significantly
reduced after pegylation19. In these cases (Meliorum,
MTI), individual measurement of the particle diameter
from SEM images was used instead of software analysis.
Nuclear T1 times of the Si nanoparticles, segregated
by size and packed dry in teflon NMR tubes, were mea-
sured at room temperature at a magnetic field of 2.9 T
using a spin-echo Fourier transform method with a sat-
uration recovery sequence. Following a train of sixteen
hard pi/2 pulses to null any initial polarization, the sam-
ple was left at field to polarize for a time τpol, followed
by a CPMG sequence (pi/2)X - [τ - (pi)Y - τ - echo]n with
τ = 1 ms and n = 200. In Si and other nuclear-dipole-
coupled materials echo sequences can yield anomalously
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FIG. 1: Electron micrographs of Si nanoparticles. (a)-(e)
ball milling high-resistivity silicon wafer, (f)-(g) wet synthesis
(Meliorum), (h) plasma synthesis (MTI), (h) electrical explo-
sion (NanoAmor), (j) ball milling low-resistivity wafer. Insets:
Volume-weighted histograms of diameters following size seg-
regation along with averages d0 and standard deviations σ
based on gaussian fits to distributions.
long decay tails20. However, the Fourier amplitude of the
echo train still provides a signal proportional to initial
polarization20. Values for T1 are extracted from expo-
nential fits, A ∝ 1− e−τpol/T1 , to the Fourier amplitude,
A, of the n = 200 echoes as a function of polarization
time (see Fig. 2a, inset for an example).
Figure 2a shows T1 as a function of (volume-weighted)
average particle diameter for the various samples. The
high-resistivity ball-milled samples follow a roughly lin-
ear dependence on size, T1 ∝ d0, for d0 <∼ 10µm, satu-
rating at T1 ∼ 5 h for larger particles. The trend of in-
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FIG. 2: (a) Nuclear spin relaxation (T1) times at 2.9 T as a
function of particle diameter d0 for various Si particles. Verti-
cal error bars are from exponential fits to relaxation data; hor-
izontal error bars are σ of size distributions (see Fig. 1). Also
shown is a core-shell diffusion model of T1 dependence on par-
ticle diameter, from Ref. 15 (dashed curve). Inset: Fourier-
transform NMR peak amplitude, A, as a function of polar-
ization time τpol (see text) for the ball-milled high-resistivity
particles with d0 = 170 nm. T1 values were measured using a
saturation recovery spin echo pulse sequence described in the
text. (b) Amplitude normalized NMR lineshape (A/Amax)
versus frequency for ball-milled high resistivity samples at
4.7 T. (c) Inhomogeneous dephasing time, T ∗2 , as a function
of mean particle diameter for ball-milled high resistivity sam-
ples at 4.7 T.
creasing T1 in larger particles is qualitatively consistent
with a simple shell-core spin diffusion model15(dotted
line), which predicts T1 ∝ d20 for particles with no in-
ternal defects or dopants. The low-resistivity ball-milled
particles have T1 ∼ 200 s, independent of size. Smaller
commercial particles formed by wet synthesis (Meliorum)
and plasma synthesis (MTI) have T1 times as long as
700 s. This is significantly longer than the predicted val-
ues, as this model assumes instantaneous spin relaxation
at the surface of the particle. Larger commercial particles
formed by electrical explosion (NanoAmor) have shorter
T1 than the comparably sized high-resistivity ball-milled
particles. Powder x-ray diffraction measurements (not
shown) indicate that ball milling induces partial poly-
crystallinity, consistent with previous studies21. We spec-
ulate that T1 is reduced for the smallest ball-milled par-
ticles, compared to the synthesized particles, by coupling
of nuclear spins to paramagnetic defects at the interface
between crystallites. Electron Spin Resonance (ESR)
measurements (see Supplementary Material S1) on ball-
milled and synthesized particles show a single peak cor-
responding to a g-factor of g=2.006, characteristic of Pb-
35mm
FIG. 3: Magnetic resonance imaging of hyperpolarized Si
nanoparticles. An H-shaped cavity filled with high-resistivity
Si particles (d0 = 1.6 µm) pre-polarized at low temperature
(T = 4.2 K) and high magnetic field (B = 5 T) for 60 h
and warmed and transferred to a 4.7 T imager. See text for
imaging details. No Si image could be obtained without hy-
perpolarization.
type defect centers22. For a fixed volume of particles, a
larger ESR signal is seen in the smaller samples, suggest-
ing that the surface, rather than the bulk, is the source
of paramagnetic defects. A detailed study relating ESR
and NMR properties will be reported later.
In addition to noting the remarkably long T1 times for
all Si measured particles relative to previously reported
hyperpolarized MRI imaging agents9,11,12,13, we also note
that T1 in the Si system can be tuned by size and dop-
ing, allowing optimization for specific applications, from
virtual colonoscopy to molecular imaging.
Averaged NMR spectra for ball-milled high-resistivity
samples of various particle sizes are shown in Fig. 2b.
Each spectrum is taken from a series of summed free in-
duction decay traces following polarization for a time 3T1
at a field of 4.7 T corresponding to 39.7 MHz, taken on a
Bruker DMX-200 NMR console. In post processing, these
spectra have been individually phase adjusted. Whereas
T1 changes by two orders of magnitude over the range of
measured particle sizes, T ∗2 changes only by factor of ∼6
over the same range. It is expected that the rapid tum-
bling of particles in a liquid suspension will increase T ∗2
considerably, restoring resolution. For biologically tar-
geted imaging, the bound particles may not tumble, but
may move enough for spectral narrowing to take place.
This will be addressed in future work.
To demonstrate MRI of hyperpolarized Si nanopar-
ticles, we filled a small cavity (in the shape of the
letter H) with high-resistivity ball-milled particles (d0
= 1.6µm). The sample was left to polarize at low-
temperature (4.2 K) and high field (5 T) for 60 h, which
enhanced the 29Si nuclear spin polarization by approxi-
mately a factor of 15 over room temperature. We then re-
moved the sample from the polarizing cryostat and trans-
ferred it to the 4.7 T Bruker DMX-200 imager with a
micro-imaging gradient set, requiring ∼ 1 minute for the
transfer, and imaged the phantom using a small tip an-
gle gradient echo sequence23. Imaging parameters were:
tip angle θ = 9◦, echo time τ = 1.2 ms, field of view =
15 mm, sample thickness = 2.5 cm, single pass (no aver-
aging), acquisition time = 11 s. The resulting image is
shown in Fig. 3. We note that much higher image reso-
lution will be possible with DNP polarization9,10,11,12,13.
To examine the applicability of Si nanoparticles to
targeted MRI, we prepared the Si nanoparticle surface
for attachment to biological-targeting ligands. Ball-
milled high resistivity nanoparticles (d0 = 200 nm) were
aminated using either (3-Aminopropyl)triethoxysilane
(APTES, Sigma, 99%) or a 1:2 mixture by volume
of APTES with bis-(triethoxysilyl)ethane (BTEOSE,
Aldrich, 96%) or (3-trihydroxysilyl)propyl methylphos-
phonate (THPMP, Aldrich, 42 wt% in H2O) (see Fig.
4 a)24. The surface oxide was first etched with a dilute
solution of hydrofluoric acid (8% in ethanol) followed by
resuspension of the particles in ethanol. Approximately
100 mg of silicon nanoparticles were added to 45 mL of
acidified 70% ethanol (0.04% v/v, adjusted to pH 3.5
with HCl) and the solution was placed in an ultrasonic
bath for five minutes. Saline (0.15 M) was then added
and the solution was shaken for 18-24 hours. Silanes
were removed from the nanoparticle solution by wash-
ing and resuspending three times in methanol buffer,
with the final resuspension performed with 10 mL of
methanol buffer. Successful amination was assessed us-
ing fluorescence spectroscopy (Fig. 4b) using an excita-
tion at 390 nm and emission at 465 nm (SpectraMax
Plus, Molecular Devices). The high level of fluorescence
observed for aminated particles results from the cova-
lent bonding of surface amino groups with fluorescamine,
showing these functional groups were accessible for fur-
ther reaction.
In addition to chemical assays, the accumulation of
amines was indirectly monitored by measuring the par-
ticles’ surface charge in solution, known as the zeta
potential25 (Fig. 4c). The surface of the unmodified sil-
icon nanoparticles is composed of hydroxyl groups from
the silicon dioxide and thus shows a negative zeta poten-
tial. Particles treated with APTES have surfaces coated
with propylamines, which become protonated and posi-
tively charged in acidic solutions and show a positive zeta
potential25.
Aminated particles were coated with polyethylene gly-
col (PEG) polymers to confer stability and biocompat-
ibility. PEG coating of silica and iron-oxide nanoparti-
cles has been shown to be non-toxic26 and to reduce the
rate of clearance by organs such as the liver or kidneys,
thus increasing the particle’s circulation time in-vivo26.
Pegylation was performed with either α-methyl-PEG-
succinimidyl α-methylbutanoate (mPEG-SMB) (Nektar)
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FIG. 4: Biological surface modification of silicon nanopar-
ticles. (a) Silicon particles (d0 = 0.2 µm) were ami-
nated using either (3-Aminopropyl)triethoxysilane (APTES)
alone or as a 1:2 mixture by volume of APTES with bis-
(triethoxysilyl)ethane (BTEOSE) or (3-trihydroxysilyl)propyl
methylphosphonate (THPMP in H2O). (b) Fluorescence spec-
troscopy confirmed the success of the amination reaction. No
fluorescence was evident with the negative control (N/C). (c)
A change in the sign of the surface charge, or zeta potential
of the particles was evident after amination with the three
amine groups when compared to the negative control.
or maleimide-PEG-N-hydroxysuccinimide (MAL-PEG-
NHS) (Nektar). Both SMB and NHS are reactive with
amines on the particle surface. 10 mg of PEG was mixed
in 500 µL of methanol buffer and heated briefly at 50 ◦C
to dissolve. Approximately 0.1 mg of aminated particles
(100 µL in solution) were added to this solution and it
was placed in an ultrasonic bath for 13 h. To remove
the unreacted PEG, samples were centrifuged and resus-
pended twice in methanol and finally in a phosphate-
buffered saline solution (PBS, 0.1 M Na2HPO4, 0.015 M
NaCl buffer).
The stability of nanoparticles in solution was assessed
using both dynamic light scattering (DLS) (Nano ZS90,
Malvern) as a measure of the particles’ hydrodynamic
radius, and visual determination of flocculation and sed-
imentation. The particles treated with mPEG-SMB and
NHS-PEG-MAL were both stable in phosphate-buffered
saline (PBS) for a period of two days, with no significant
change in the particles’ hydrodynamic radius (see Sup-
plementary Information S2). As a control, mPEG-Amine
polymer, which does not contain amine-reactive groups,
was used. The aminated particles treated with mPEG-
Amine aggregated after centrifugation and resuspension
in PBS. These results are consistent with other reports
of the successful pegylation of SiO2 nanoparticles19,27.
In conclusion, we demonstrate that Si nanoparti-
cles show promise as biologically targeted MRI imaging
agents based on their exceptional NMR properties, in-
cluding their receptivity to hyperpolarization and long
nuclear relaxation (T1) times, in the range of minutes
to hours. We investigated Si T1 times as a function
of nanoparticle size, dopant concentration and synthesis
method. Furthermore, we have demonstrated techniques
for fabricating, size-separating and coating Si nanoparti-
cles to satisfy a broad spectrum of design criteria. Future
developments in the chemical synthesis of larger, mono-
disperse single-crystal silicon nanoparticles may provide
even longer T1 times. We note that Si nanoparticles may
be combined with other material components to provide
MRI tracking of the delivery of drugs28 or as a therapeu-
tic agent that allows simultaneous MRI tracking. The
addition of APTES and PEG to the surface of these
nanoparticles is a critical step for further surface func-
tionalization and, ultimately, biological targeting.
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